Professional Documents
Culture Documents
Significant Early In-Hospital Benefit Was Seen. Clopidogrel Is Prefferd To
Significant Early In-Hospital Benefit Was Seen. Clopidogrel Is Prefferd To
Patients; n RCTs; n
Anticoagulant
Cardiac Rehabilitation
Beta-Blockers
Cholesterol Reduction
Antplatelet agents
ACE Inhibitors
Calcium Antagonists
Class 1 Antiarrhythm
Amiodarone
4975
5022
24298
10775
18411
5984
13114
6300
1557
12
23
26
8
10
3
6
18
9
0.5
9. Lifestyle advice ismost important and all patients should cease smoking and
receive advice on exercise an diet. Diabetes should be tightly controlled.
MYOCARDIAL INFRACTION IN THE INTENSIVE CARE UNIT
Myocardial ischemia is acommon problem in thr ICU. It also commonly complicates
perioperative care of major surgery, with mortality of up to 15-25%. Diagnostic
criteria are uncertain but a system has been proposed by Devereaux et al.There are
few randomized controlled trials to guide therapy of postoperative infarction, or
infarction complicating the care of critically ill. Many patients with such
presentations were excluded from trials of ACS therapy.
The pathophysiology of postoperative infarction and infarction in ICU
patients is probably different to that of ACS. Studies suggest that, in the presence of
severe ischaemia, left main disease and triple-vessel disease are common and that
ischemia is secondary to oxygen supply and demand problems rather than
thrombosis. However, data on this are conflicting. The absence of thrombosis as an
underlying pathological mechanism in many suggest that standard aggressive
antithrombus therapies will have different risk-benefit profiles, and that harm is
exacerbated by the often high bleeding risk of these patients.
The patiens with significant ST-segment elevation and haemodynamic
instability in the ICU present a difficult problem. Where underlying coronary artery is
considered likely, an invasive approach is usually necessary.Thrombolysis is usually
precluded by bleeding risk and by uncertainty regarding the causative process.
Angiography will allow diagnosis and intervention if necessary; however, the use of
adjunctive therapy (short-and intermediate term) may be associated with significant
bleeding. Reversible factors such as hypoxia, severe anaemia, anxiety andtachycardia
must all be controlled where possible. Hypotension may limit the ability to administer
-blockers and control tachycardia.
Echocardiography may be useful in confirming regional wall motion
abnormality and in confirming the amount of myocardium at risk. Of Interest is the
Takotsubo syndrome, where anterior ST-segment elevation and tipical ballooning an
echocardiography, often in association with elevated troponins, may occur in the
presence of normal coronary arteries.
BLEEDING COMPLICATIONS POSTREPERFUSION THERAPY
The increased use of aggressive fibrinolytic regimens and adjunctive reperfusion
agents has led to troublesome bleeding in some patients. Some knowledge of reversal
of these agents is necessary.
1. GPIIb/IIIa blockers,Abciximab, a chimeric monoclonal antibody, has a short halflife, but antipletelet activity is still prolonged at 24-28 h. Fortunately transfused
platelet are not affected and will assist with bleeding reversal. The newer agent
tirofiban and eptifibitide have very short half-life and antiplatelet action returns to
normal 4-8 h after discontinuation. During this periode, however, antipletelet
action is profound. It is suggested that administration of fresh frozen plasma (8
units) and platelets (2 units)is likely necessary to reverse antiplatet action.
2. Clopidogrel. It is recommendedthat clopidogrel be ceased at least 5 days before
elective CABG, but this is not always possible in emergent surgery or in unstable
cases. Major bleeding rates may approach10% in these cases. Phrmacology
suggest that platelet transfusionare necessary to moderate this but dose is
unknown.
3. LMWHs. Reversal of LMWHs with protamine is variable and incomplete, even
with doses of 100 mg. Protamine may reverse up to 60% of LMWH action. It
suggested that doses of protamine should equal doses of enoxaparin administrated
on a milligram-per-milligram scale
4. Fibrinolytic agents. In the setting of life-threatening bleeding, large doses of
cryoprecipitate (10-20 units) may be required to replace fibrinogen (target > 1g/l)
and coagulation factors (especially factor VIII). Fresh frozen plasma may
supplement factor V and VIII levels. Platelet transfusionsat high dose may replace
platelets and supplement factor V levels. -Aminocaproic acid at a dose of 5 g
(0.1 g/kg) over 30-60min followed by continuous infusion (0.5-1.0 g/h) may
assist with bleeding control.
OUTCOME OF MYOCARDIAL INFARCTION
The in-hospital mortality from acute MI has been steadily decreasing over the past
three decades from 15% to 30% in the 1970s to approximately 10% in 1980 and now
to around 8-9 % in the new millennium. Despite improved mortality, 60 % of all
deaths occur within the first hour (usually from VF), and usually before reaching a
medical facility. Modern management of acute MI has undoubtedly contributed to
decreased mortality. Further significant reduction in mortality must come from
management strategis within the first hours of the onset of symptoms.
The letter cannot be underestimated. In one study, the in-hospital mortality was 5.7%
for those who were eligible for but did not receive such therapy (9.3% versus 18% in
eligible women who did not receive therapy, 10.5% versus 1% in eligible elderly). Up
to 24% of eligible patients di not receive reperfussion therapy.
NEW INFORMATION
The conclusion can be summarized.
Cardiac troponin level is frequently increased in hospitalized patients in the
absence of an ACS
It portends poor short and long term outcomes
Most of these patients have an alternative explanation for cardiac troponin
increase
Cardiac diagnostic procedures are frequently unhelpful in excluding a non-ACSrelated troponin increase
Essentially Troponin 1 level had poor accuracy in discriminating patients with and
without ACS. Alternative diagnoses included; xepsis, acute left heart failure,
cerebrovascular events and wide range of other conditions